RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Effect of Anagliptin and Sitagliptin in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: What Is the Real REASON Behind It?

Effect of Anagliptin and Sitagliptin in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: What Is the Real REASON Behind It?

Add to Collection
2018 Jun Others Fist_Author_Year_PM

Full Author : ['Jonnalagadda, Venu Gopal', 'Char, Harish Prabhanna', 'Ankana, Praveen Kumar']
Journal Title : Cardiovascular drugs and therapy
Chapter : Section3
Journal Year : 2018
Cited by : Not Available

.....

Keywords : ["type diabetic patient", "real reason behind", "cardiovascular risk", "sitagliptin", "effect", "dyslipidemia", "anagliptin"]